1-Butanamine, 3-methyl-N-(3-methylbutylidene)-
Common Name: |
1-Butanamine, 3-methyl-N-(3-methylbutylidene)- |
IUPAC Name: |
3-methyl-N-(3-methylbutyl)butan-1-imine |
Molecular Formula: |
C10H21N |
SMILES: |
CC(C)CCN=CCC(C)C |
Inchi: |
1S/C10H21N/c1-9(2)5-7-11-8-6-10(3)4/h7,9-10H,5-6,8H2,1-4H3 |
Inchi Key: |
WYNULUURQZBBSK-UHFFFAOYSA-N |
Cas No: |
35448-31-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
155.28 |
Mass (g/mol) |
155.167 |
Molar Refractivity |
53.87 |
Net Charge |
1 |
HBD |
|
HBA |
1 |
Rt Bonds |
5 |
Rings |
|
TPSA |
12.36 |
Hetero Atoms |
1 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
145.00 to 148.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.239 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
3.149 |
iLOGP |
3.01 |
XLOGP3 |
2.79 |
WLOGP |
3.15 |
MLOGP |
2.70 |
ESOL Log S |
-2.23 |
ESOL Solubility (mg/ml) |
0.913 |
ESOL Solubility (mol/l) |
0.006 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.71 |
Ali Solubility (mg/ml) |
0.31 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.82 |
Silicos-IT Solubility (mg/ml) |
0.24 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.27 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.787 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.19 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |